FWM
HALO icon

Frontier Wealth Management’s Halozyme HALO Stock Holding History

Frontier Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,100
Closed -$131K – 396
2017
Q1 		$131K Hold
10,100
– – 0.02% 380
2016
Q4 		$100K Sell
10,100
-200
-2% -$2.19K 0.02% 383
2016
Q3 		$124K Sell
10,300
-1,100
-10% -$11.2K 0.02% 349
2016
Q2 		$98K Buy
11,400
+200
+2% +$1.97K 0.02% 316
2016
Q1 		$106K Buy
11,200
+200
+2% +$1.88K 0.01% 335
2015
Q4 		$191K Buy
+11,000
New +$175K 0.03% 322

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Frontier Wealth Management's HALO Position: Q2 2017 in Review

Frontier Wealth Management sold out of Halozyme (HALO) in Q2 2017, closing a stake of 10,100 shares — an estimated $131K sold.

Frontier Wealth Management first reported a position in HALO in Q4 2015 and held it in 6 quarters. The position peaked at $191K in Q4 2015. 167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

  • Frontier Wealth Management reported no remaining Halozyme position as of Q2 2017 after selling out during the quarter.
  • Frontier Wealth Management sold 10,100 Halozyme shares in Q2 2017, an estimated $131K.
  • Frontier Wealth Management first reported a position in Halozyme in Q4 2015 and held it in 6 quarters.
  • Frontier Wealth Management's Halozyme position peaked at $191K in Q4 2015.
  • 167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on Frontier Wealth Management's 13F filing for Q2 2017, filed 14 Aug 2017.